氨溴索雾化吸入治疗老年慢性支气管炎急性发作(喘息型)48例临床观察  

Clinical Observation of 48 cases of Atomizing Inhalation of Ambroxol Hydrochloride in Treatment of Acute Exacerbation of Chronic Bronchitis (Asthmatic)

作　　者：张静 

机构地区：[1]郫县中医院,四川成都611730

出　　处：《中国医药指南》2012年第34期413-415,共3页Guide of China Medicine

摘　　要：目的突显氨溴索雾化吸入治疗老年慢性支气管炎急性发作(喘息型)的比较优势,探讨老年慢性支气管炎的临床治疗方法,总结治疗经验。方法将48例老年慢性支气管炎急性发作(喘息型)患者随机平均分为:对照组,采用常规治疗方法;治疗组在对照组基础治疗上+氨溴索雾化吸入;每组各24人,统计对比二组患者的临床治疗效果。结果二组患者经过治疗后,发热、喘息、咳嗽、肺部啰音等临床症状消失时间,治疗组明显短语对照组,疗效价值突出。治疗组治疗总有效率95.8%相较对照组的83.3%明显改善,加用氨溴索雾化吸入治疗效果提高12.5%,结果具有统计学意义(P<0.05)。结论加用氨溴索雾化吸入治疗老年慢性支气管炎急性发作(喘息型)的祛痰镇咳效用价值优越,用药安全性好且疗效肯定,临床上应加以利用、大力推广,发挥其药用价值。Objective Summary of clinical experience about ambroxol in treatment of acute exacerbation of chronic bronchitis（asthmatic）.Methods 48 patients were randomly divided into two groups： control group,using conventional treatment methods;treatment group,basic of control group treatment and plus atomizing inhalation of ambroxol.Results After treatment,The total effective rate of treatment group is 95.8%,The control group was 83.3%,difference has statistical significance（P0.05）.Conclusion Ambroxol efficacy is superior,is worth the clinical promoted.

关 键 词：氨溴索 老年慢性支气管炎急性发作(喘息型) 雾化吸入 

分 类 号：R562.21[医药卫生—呼吸系统]